AS 101

Known as: AS-101, AS101 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2018
024619872018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Inflammatory bowel diseases (IBDs) are a group of idiopathic, chronic immune-mediated diseases characterized by an aberrant… (More)
Is this relevant?
2007
2007
Ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) is a non-toxic organotellurium compound with pleiotropic activities. It… (More)
Is this relevant?
2002
2002
The role of IL-10 in experimental sepsis is controversial. The nontoxic immunomodulator, ammonium trichloro(dioxoethylene-o,o… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table I
Is this relevant?
2000
2000
Optimal doses of paclitaxel (Taxol) combined with the immunomodulator AS101, previously shown to have anti-tumoral effects… (More)
Is this relevant?
1997
1997
AS-101 is a tellurium-based compound with known immunomodulating properties. The ability of AS-101 to potentiate the effects of… (More)
Is this relevant?
1996
1996
The immunomodulator AS101 has been demonstrated to exhibit radioprotective and chemoprotective effects in mice. Following phase-I… (More)
Is this relevant?
1996
1996
BACKGROUND Several studies have recently suggested that the immune response to malignant growths is regulated by distinct… (More)
Is this relevant?
1995
1995
PURPOSE The aim of this study was to evaluate the ability of the immunomodulator AS101 to prevent chemotherapy-induced… (More)
Is this relevant?
1995
1995
The immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate (AS101) has previously been found by us to have… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1987
1987
There has been interest in the potential of synthetic compounds to modify immune responses by imitation of cytokine action… (More)
Is this relevant?